Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5136)
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
5,256
Price
$161.64
Total Value
$849.58K
Shares Held After
3,258,453
% of Holdings
0.2%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
4,579
Price
$160.50
Total Value
$734.93K
Shares Held After
3,263,709
% of Holdings
0.1%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
11,760
Price
$159.57
Total Value
$1.88M
Shares Held After
3,268,288
% of Holdings
0.4%
SI-BONE, Inc. (SIBN)
Davis Timothy E JR — Director
Shares
3,500
Price
$14.14
Total Value
$49.49K
Shares Held After
65,722
% of Holdings
5.1%
Ascendis Pharma A/S (ASND)
SMITH SCOTT THOMAS — EVP & Chief Financial Officer
Shares
250
Price
$223.32
Total Value
$55.83K
Shares Held After
4,267
% of Holdings
5.9%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
100
Price
$223.50
Total Value
$22.35K
Shares Held After
900
% of Holdings
11.1%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$222.30
Total Value
$44.46K
Shares Held After
800
% of Holdings
25.0%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$223.76
Total Value
$44.75K
Shares Held After
600
% of Holdings
33.3%
CRISPR Therapeutics AG (CRSP)
Patel Naimish — Chief Medical Officer
Shares
3,786
Price
$55.62
Total Value
$210.58K
Shares Held After
19,357
% of Holdings
16.4%
WORK Medical Technology Group LTD (WOK)
HRT FINANCIAL LP — 10% Owner
Shares
2,619,607
Price
$0.10
Total Value
$261.96K
Shares Held After
0
% of Holdings
100.0%
ILLUMINA, INC. (ILMN)
Ericksen Scott D — VP, Chief Accounting Officer
Shares
500
Price
$160.00
Total Value
$80.00K
Shares Held After
14,446
% of Holdings
3.3%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,129
Price
$2.57
Total Value
$5.47K
Shares Held After
9,970
% of Holdings
21.4%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,786
Price
$2.57
Total Value
$4.59K
Shares Held After
17,131
% of Holdings
10.4%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,829
Price
$2.57
Total Value
$4.70K
Shares Held After
9,840
% of Holdings
18.6%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,582
Price
$2.57
Total Value
$4.07K
Shares Held After
9,176
% of Holdings
17.2%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,292
Price
$2.57
Total Value
$5.89K
Shares Held After
10,758
% of Holdings
21.3%
ILLUMINA, INC. (ILMN)
Davies Scott M — Chief Legal Officer
Shares
615
Price
$160.00
Total Value
$98.40K
Shares Held After
21,568
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$559.41
Total Value
$179.01K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
841
Price
$558.81
Total Value
$469.96K
Shares Held After
40,833
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
918
Price
$557.80
Total Value
$512.06K
Shares Held After
41,674
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
461
Price
$556.67
Total Value
$256.62K
Shares Held After
42,592
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,000
Price
$555.59
Total Value
$555.59K
Shares Held After
43,053
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
817
Price
$554.57
Total Value
$453.08K
Shares Held After
44,053
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
823
Price
$553.73
Total Value
$455.72K
Shares Held After
44,870
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$552.58
Total Value
$375.75K
Shares Held After
45,693
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
986
Price
$551.34
Total Value
$543.62K
Shares Held After
46,373
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,605
Price
$550.60
Total Value
$883.71K
Shares Held After
47,359
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
769
Price
$549.59
Total Value
$422.64K
Shares Held After
48,964
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$548.60
Total Value
$153.61K
Shares Held After
49,733
% of Holdings
0.6%
Monte Rosa Therapeutics, Inc. (GLUE)
Townson Sharon — Chief Scientific Officer
Shares
6,000
Price
$19.87
Total Value
$119.22K
Shares Held After
67,845
% of Holdings
8.1%
MediWound Ltd. (MDWD)
Rubinstein Samuel — Director
Shares
150
Price
$14.33
Total Value
$2.15K
Shares Held After
2,993
% of Holdings
5.0%
Personalis, Inc. (PSNL)
Hall Christopher M — Director
Shares
80,091
Price
$11.02
Total Value
$882.60K
Shares Held After
235,986
% of Holdings
25.3%
Personalis, Inc. (PSNL)
Tachibana Aaron — CFO AND COO
Shares
38,799
Price
$11.58
Total Value
$449.29K
Shares Held After
198,833
% of Holdings
16.3%
NEXGEL, INC. (NXGL)
Levy Adam R. — Director
Shares
3,000
Price
$0.60
Total Value
$1.80K
Shares Held After
344,692
% of Holdings
0.9%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
32,556
Price
$0.45
Total Value
$14.65K
Shares Held After
622,579
% of Holdings
5.0%
Alkermes plc. (ALKS)
Parisi Samuel Joseph — VP, Finance (Interim PAO)
Shares
16,217
Price
$42.36
Total Value
$687.01K
Shares Held After
7,717
% of Holdings
67.8%
Edwards Lifesciences Corp (EW)
Dahl Andrew M. — SVP, Corporate Controller
Shares
568
Price
$86.08
Total Value
$48.85K
Shares Held After
15,334
% of Holdings
3.6%
CHEMED CORP (CHE)
WALSH GEORGE J III — Director
Shares
500
Price
$437.83
Total Value
$218.91K
Shares Held After
3,209
% of Holdings
13.5%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,192
Price
$236.97
Total Value
$282.47K
Shares Held After
52,626
% of Holdings
2.2%
Q32 Bio Inc. (QTTB)
ORBIMED ADVISORS LLC — Director
Shares
625,000
Price
$8.00
Total Value
$5.00M
Shares Held After
625,000
% of Holdings
100.0%
Q32 Bio Inc. (QTTB)
ORBIMED ADVISORS LLC — Director
Shares
1,250,000
Price
$8.00
Total Value
$10.00M
Shares Held After
3,502,987
% of Holdings
35.7%
Q32 Bio Inc. (QTTB)
Xu Diyong — Director
Shares
625,000
Price
$8.00
Total Value
$5.00M
Shares Held After
625,000
% of Holdings
100.0%
Q32 Bio Inc. (QTTB)
Xu Diyong — Director
Shares
1,250,000
Price
$8.00
Total Value
$10.00M
Shares Held After
3,502,987
% of Holdings
35.7%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Ghiath M. — Director
Shares
8,539,709
Price
$0.59
Total Value
$5.00M
Shares Held After
22,092,068
% of Holdings
38.7%
AUNA S.A. (AUNA)
Zamora Leon Jesus — Director
Shares
9,220
Price
$4.17
Total Value
$38.45K
Shares Held After
55,134
% of Holdings
16.7%
AUNA S.A. (AUNA)
Wilton John — Director
Shares
17,574
Price
$4.17
Total Value
$73.30K
Shares Held After
49,974
% of Holdings
26.0%
Medline Inc. (MDLN)
Shares
1,262,726
Price
$36.54
Total Value
$46.14M
Shares Held After
6,519,062
% of Holdings
16.2%
Medline Inc. (MDLN)
Shares
11,904,646
Price
$36.54
Total Value
$434.97M
Shares Held After
62,591,526
% of Holdings
16.0%
Medline Inc. (MDLN)
Shares
753,528
Price
$36.54
Total Value
$27.53M
Shares Held After
3,422,699
% of Holdings
18.0%
Medline Inc. (MDLN)
Shares
17,947,337
Price
$36.54
Total Value
$655.75M
Shares Held After
228,840
% of Holdings
98.7%
Showing 501–550 of 5136 transactions (page 11 of 103)